SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-136743
Filing Date
2016-11-28
Accepted
2016-11-28 17:07:19
Documents
4
Period of Report
2016-11-22
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v453982_8k.htm 8-K 19790
2 EXHIBIT 16.1 v453982_ex16-1.htm EX-16.1 4372
3 GRAPHIC image_001.jpg GRAPHIC 1451
4 GRAPHIC image_002.jpg GRAPHIC 1672
  Complete submission text file 0001144204-16-136743.txt   29982
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-191083 | Film No.: 162020551
SIC: 2834 Pharmaceutical Preparations